Intravenous access is a way to quickly restore iron in the blood stream using a small tube that contains iron drugs.The market encompasses various types of iron drugs such as ferric carboxymaltose,sucrose, dextran, and others.The global intravenous iron drugs market is expected to benefit from the rising incidence of iron deficiency anemia and increase in risk factors that cause iron deficiency such as kidney disorders. Kidney diseases cause iron deficiency due to the lowered production of erythropoietin, which reduces the red blood cell count. For instance, according to the Centers for Disease Control and Prevention (CDC) 2014 statistics, more than 20 million individuals have chronic kidney diseases in the US.However, the number of individuals with diagnosed kidney disease was only 4.5 million in the same year. Therefore, there is an increased need to develop effective therapeutics for the treatment of iron deficiency.

PART 01: Executive summary 6

PART 02: Scope of the report 17

PART 03: Research Methodology 22

PART 04: Introduction 25

Key market highlights 25

PART 05: An overview of iron deficiency 26

PART 06: Pipeline landscape 27

PART 07: Market landscape 28

Market overview 28

Five forces analysis 31

PART 08: Market segmentation by product type 32

Ferric carboxymaltose 32

Sucrose 34

Dextran 35

Others 36

PART 09: Geographical segmentation 38

Intravenous iron drugs market in Americas 39

Intravenous iron drugs market in EMEA 41

Intravenous iron drugs market in APAC 43

PART 10: Decision framework 45

PART 11: Drivers and challenges 47

Market drivers 48

Impact of drivers on key customer segments 50

Market challenges 51

Impact of challenges on key customer segments 54

PART 12: Market trends 55

Increase in favorable guidelines from healthcare

organizations 55

Increasing strategies of vendors to expand reach of

intravenous iron drugs 55

Growing focus on emerging economies 56

PART 13: Vendor landscape 57

Competitive scenario 57

PART 14: Key vendor analysis 60

Allergan 60

AMAG Pharmaceuticals 62

Daiichi Sankyo 65

Galenica 68

Pharmacosmos 71

Other prominent vendors 74

PART 15: Appendix 75

List of abbreviation 75

PART 16: Explore Technavio 76